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The present review includes the analysis of known literature data concerning linear and multicom-
ponent heterocyclizations involving pyruvic acids and aminoazoles. In particular, the review 
demonstrates the approaches to control regio- and chemoselectivity of these types of treatments and 
their application to solve the matters of Diversity Oriented Synthesis. 
________________________________________________________________________________ 
Introduction 
The significance of pyruvic acid in our 
life can be hardly overestimated. It plays a vital 
role as one of the most reactive substances 
among those of important in cellular metabo-
lism. That is why a conclusion may be made 
that reactions involving pyruvic acid may help 
to solve some health problems and assist in 
finding a cure against various diseases today 
and in future. Heterocyclization reactions of py-
ruvic acids with nitrogen containing nucleo-
philes play an important role in the synthesis of 
heterocyclic compounds having diverse types of 
physiological activities such as antimalarial [1, 
2], antitumor [3], antimicrobial [4], antifungal 
[5] and analgesic [6–8] activities. Thus, study of 
chemical behavior of pyruvic acid and its deriv-
atives in chemical reactions are interesting from 
several points of view. 
The first multicomponent reaction in-
volving pyruvic acid was discovered in the late 
19th century [9, 10] by Doebner - the three-
component condensation of pyruvic acid, alde-
hydes and aniline derivatives leading either to 
quinoline carboxylic acids or to pyrrolidine-2,3-
diones (Scheme 1). Further this reaction was 
studied in details in numerous publications [3, 
11-22]. 
Initially, it had been considered that the 
Doebner reaction proceeded via formation of 
arylidenepyruvic acid [11], however, later that 
way was refuted and an alternative mechanistic 
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pathway involving the formation of a Schiff 
base followed by cyclization was proposed [15, 
18, 19]. 
 
Scheme 1. 
On the other hand, reaction of aryli-
denepyruvic acids and aromatic amines led to 3-
arylamino-5-aryl-2(5H)furanones [20] but not to 
pyrrolidine-2,3-diones as it had been reported 
earlier (Scheme 1) [21]. It should be noted that 
different procedures for Doebner reaction were 
developed [23-27] based on the variation of sol-
vents, catalysts and activation methods. 
The Doebner-like multicomponent reac-
tions of phenylpyruvic acid with aromatic alde-
hydes and aromatic amines, also yielded either 
pyrrolidine-2,3-dione or quinoline-4-carboxylic 
acid depending on substituents R1 and R2 
(Scheme 2) [12].  
 
Scheme 2. 
However, in this case no clear relation-
ship between the electronic character of the sub-
stituents and structure of the reaction products 
was established. 
An interesting approach to the synthesis 
of quinoxaline derivatives via Ugi-type reaction 
was proposed as well (Scheme 3) [28]. Thus, 
the four-component reaction of the starting rea-
gents in MeOH yielded the Ugi adducts, which 
by means of acid catalysis turned into quinoxa-
linones. 
Scheme 3. 
Such type of Ugi reaction allowed to 
synthesize a wide range of quinoxaline deriva-
tives having different types of biological activi-
ties: among them inhibitors of various enzymes, 
as well as benzodiazepine receptor agonists 
were found [28]. 
Some publications deal with arylpyruvic 
acids as α-ketoacids and describe their trans-
formations with 1,2-diamines also yielding 
quinoxalines or analogous heterocyclic systems. 
[29-32] 
In publication [33] it was shown that 
Biginelli-like condensation of arylpyruvic acids 
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with aromatic aldehydes and urea in the pres-
ence of catalytic amounts of acid yielded dihy-
dropyrimidine carboxylic acids (Scheme 4). 
Similar pyrimidines were synthesized by using a 
polymer-supported solid-phase procedure [34]. 
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Scheme 4. 
There are a lot of papers about already 
known and currently studied biological activity 
of azoloazine structures, e.g. antifungal [35] and 
antimicrobial [35, 36], hypoglycemic activity 
[37], in particular, (DPP4) inhibition [38], car-
diovascular activity [39], etc. However, multi-
component procedures involving pyruvic acid or 
its derivatives, aromatic aldehydes, and hetero-
cyclic amines, for example aminoazoles, have 
been previously rarely investigated. Aside from 
our publications which are discussed in the 
General part of the review, recently, we have 
found some publications in the literature devot-
ed to the reactions involving pyruvic acid and 
its derivatives with aminoazoles. Li-Yan Zeng 
and coworkers reported one-pot treatment of 
pyruvic acid with 5-aminotetrazole and structur-
ally diverse aryl aldehydes which gave 5-aryl-
5,8-dihydrotetrazolo[1,5-a]pyrimidine-7-
carboxylic acids (Scheme 5) [40, 41]. 
 
Scheme 5. 
In publication [42] it was considered that 
multicomponent reaction involving pyruvic acid 
and 5-amino-1-phenyl-3-(pyridine-3-yl)-1H-
pyrazole with aromatic aldehydes in boiling 
acetic acid gave 4-substituted-1-phenyl-3-
(pyridin-3-yl)-1H-pyrazolo[3,4-b]pyridine-6-
carboxylic acids in 54-75% yields (Scheme 6). 
The reactions were carried out by two different 
techniques – by conventional heating and under 
microwave irradiation. The compounds obtained 
were screened for their antibacterial and anti-
tumor activities with positive results. 
 
Scheme 6. 
It should be noted, that multicomponent 
cyclization of 5-amino-3-methyl-1-phenyl-1H-
pyrazole with aromatic aldehydes and ethyl py-
ruvate led to the formation of a different set of 
pyrazolo[3,4-b]pyridine-4-carboxylates as reac-
tion product [43] (Scheme 7), instead of pyra-
zolopyridines described above [42]. 
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Scheme 7. 
In vitro biological evaluation of pyra-
zole[3,4-b]pyridine derivatives, as a new an-
tichagasic agent series, were carried out [43]. 
 
General part 
One of the first reactions [44] involving 
pyruvic acids and aminoazoles was two-
component condensation (Scheme 8). The pre-
liminary treatment of pyruvic acid (1) and alde-
hydes 2 gave the starting arylidenepyruvic acids 
3 which further reacted with 5-aminotetrazole 
(4) upon heating in DMF leading to dihydro-
tetrazolopyrimidine carboxylic acids 5 (Scheme 
8). 
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Scheme 8. 
Afterwards the potential biological activ-
ity of the compounds 5 was studied with the 
help of computational analysis using the system 
PASS-C&T 4.00. The results of the screening 
showed that dihydrotetrazolopyrimidines 5 
might possess cardiovascular, anticonvulsant, 
cardioprotector and fibrinolytic types of activi-
ty. 
However, the authors [45] mentioned 
about one significant drawback in the described 
reaction. The first stage of that procedure gave 
arylidenpyruvic acids 3 in very low yields (15–
30%) while the second stage yields were within 
40–60% range and the general efficiency of this 
two-staged reaction was unsatisfactory. There-
by, the next publications were dedicated to the 
applying multicomponent reactions as an alter-
native pathway for the synthesis of azolopyrim-
idine carboxylic acid derivatives from appropri-
ate aminoazoles, aromatic aldehydes and pyru-
vic acids. 
Refluxing 5-aminotetrazole (4), aromatic 
aldehydes 2 and pyruvic acid (1) in DMF or 
glacial acetic acid led to the formation of the 
same fused dihydropyrimidines 5 (Scheme 9) 
that allowed to save time, reagents and to en-
hance the yields [45]. 
 
Scheme 9. 
Nowadays there is a wide set of ap-
proaches for controlling the selectivity of multi-
component reactions such as classical ones like 
variation of the parameters of the reaction me-
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dium (e.g. the solvent and catalyst types, time 
regime etc.) and non-classical methods like mi-
crowave and ultrasonic irradiation, etc. Moreo-
ver, modification of the structures of the starting 
reagents, thereby increasing their polyfunction-
ality, may also considerably influence the reac-
tion proceeding and cause the formation of dif-
ferent types of final heterocycles [46-51]. 
In the publications [45, 52, 53] an influ-
ence of substituents in the aldehyde and pyruvic 
acid components on a proceeding their hetero-
cyclizations with 3-amino-1,2,4-triazole deriva-
tives was studied. Particularly, variation of the 
temperature regime together with applying non-
classical activation methods (ultrasonic and mi-
crowave irradiation) allowed to switch the reac-
tion between several directions and to obtain 
selectively several chemotypes of final struc-
tures. 
Thus, the behavior of 3-amino-1,2,4-
triazole (6) in the three-component condensation 
with aromatic aldehydes 2 and pyruvic acid (1) 
turned up to be quite the same to the 5-
aminotetrazole (4) reactivity [45]. Refluxing 3-
amino-1,2,4-triazole (6) and aromatic aldehydes 
2 with pyruvic acid (1) in glacial acetic acid al-
lowed to isolate from the reaction mixtures the 
pure acids 8 with good yields (Pathway B, 
Scheme 10). At the same time, heating the start-
ing compounds 1, 2 and 6 in DMF led to mix-
tures of two regioisomeric dihydrotriazolopy-
rimidines 8 and 9 (Pathway D, Scheme 10). All 
attempts to separate these mixtures by crystalli-
zation or using HPLC were unsuccessful [45, 
53]. 
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Scheme 10. 
Over time, Murlykina et al. [53] discov-
ered that decreasing the temperature up to 65 °C 
in the reaction of the same starting materials 1, 
2 and 6 led to the formation of tetrahydropyrim-
idines 7 (Pathway A, Scheme 10). It should be 
noted that boiling the compounds 7 in acetic ac-
id for 4 hours via decomposition / heterocycliza-
tion / dehydratation sequence [45] also led to 
the formation of heterocycles 8 (Pathway C, 
Scheme 10). 
On the contrary, heating the compounds 
11, derived from 2-hydroxybenzaldehyde 10, in 
HOAc led to the tarring of the reaction mixture, 
and no individual product was isolated. Howev-
er, their MW irradiating in MeOH (140 °C, 50 
min) finally allowed to get dihydropyrimidines 
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12 (Scheme 11). Decreasing the reaction tem-
perature up to 130 °C yielded the mixture of two 
regioisomeric compounds 12 and 13 [53]. The 
authors [53] varied the temperature, solvents 
and different catalysts, however, neither an in-
creasing the yield of 12 nor a selective isolation 
of compounds 13 was achieved. All attempts to 
obtain dihydropyrimidines 12 or 13 in the three-
component condensation were also unsuccess-
ful. 
 
Scheme 11. 
As it was mentioned before multicom-
ponent reactions involving arylpyruvic acids 
and aminoazoles leading to heterocyclic com-
pounds have been rarely investigated, thereby, it 
was interesting to disclose an influence of an 
introduction of a β-aryl substituent into pyruvic 
acid on the reaction proceeding. Thus, the au-
thors [52, 53] disclosed the results on the tuning 
multicomponent condensation reactions of 5-
aminotetrazole (4) or 3-amino-1,2,4-triazole de-
rivatives 6 and 14 with aldehydes and arylpyru-
vic acids using both traditional and non-
classical activation methods. It was found that 
the condensation of aminotriazoles 6, 14 with 
arylpyruvic acids 15 and aromatic aldehydes 2 
in boiling acetic acid led to different products 
depending on the reaction conditions. Particu-
larly, tetrahydrotriazolopyrimidine carboxylic 
acids 16 were isolated after refluxing equimolar 
amounts of the starting materials 2, 15 and 6 or 
14 in acetic acid for 2-3 minutes while reaction 
for 180 minutes provided pyrrolones 17. Reac-
tion times within those extremes in most cases 
led to the formation of both heterocycles 16 and 
17 (Scheme 12). 
The experimental data obtained [52] in-
dicated that in this three-component condensa-
tion (Scheme 12) the fused pyrimidines 16 were 
the kinetically controlled reaction products 
while pyrrolones 17 might be considered as the 
thermodynamically controlled products. In addi-
tion, the authors applied ultrasonic and micro-
wave irradiation: treatment the starting materials 
2, 15 and 6 or 14 for ca. 30 minutes under ultra-
sonication yielded exclusively fused triazolopy-
rimidinecarboxylic acids 16 and these condi-
tions were chosen as the optimal ones; on the 
other hand, MW irradiating the mixture of the 
same starting materials in acetic acid at 170 °C 
allowed to obtain pyrrolones 17 with almost 9-
fold time reduction as compared with the ther-
mal heating [52, 53]. 
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Scheme 12. 
Afterwards the studies of antibacterial 
and antiviral activities of the compounds syn-
thesized were carried out in vitro [53]. The test-
ed substances didn’t show high antibacterial ac-
tivity, however, for several of them sufficient 
increase in biomass of test-cultures compared 
with control was found. The promising result 
was also obtained for pyrrolone 17 (R1 = 2-
CH3OC6H4). This compound showed high activ-
ity against influenza A/H1N1 with an average 
IC50 value of 0.57 μM and a CC50 >100 μM. 
The reference compound amantadine had an 
IC50 of 13.5 μM, demonstrating that compound 
17 was at least 20-fold more active than the ref-
erence drug. 
Multicomponent condensations involv-
ing 5-aminotetrazole (4) in boiling acetic acid 
(or with applying MW irradiation) provided the 
formation of only pyrrolones 18 being analo-
gous to 17 and all the attempts to get fused py-
rimidines of type 16 remained unsuccessful [52] 
(Scheme 13). 
 
Scheme 13. 
This fact was explained by Sakhno et al. 
[52] regarding the mechanistic aspects of these 
reactions (Scheme 14). Thus, the three-
component reaction of the starting materials 2, 
15 and 6 or 14 at room temperature giving tria-
zolopyrimidines 16 most probably proceeded 
via the initial formation of azomethines 19 and 
their subsequent reaction with arylpyruvic acids 
15 which was not a synchronous process 
(pathway “a”, Scheme 14). The authors [52] 
indirectly proved this assumption by the treat-
ment of preliminary synthesized Schiff base 19 
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with arylpyruvic acids 15 yielding triazolopy-
rimidines 16 and by observation of compounds 
of type 19 in trace amounts in the mother liquor 
of the multicomponent reaction. 
According to the hypothesis [52] 5-
aminotetrazole (4) formed no azomethine with 
aldehydes and, therefore, the appropriate te-
trazolopyrimidines were not isolated. 
The pathway of high-temperature reac-
tion leading to pyrrolones 17 and 18 is also unu-
sual and its mechanism seems unclear. In this 
condensation aminoazoles 4, 6, 14 act as mono-
nucleophiles like anilines [54, 55]. Described in 
the literature [56] related three-component reac-
tion of anilines, pyruvic acids and aldehydes 
proceeds through the formation of furanone de-
rivatives like 20 (pathway “b”, Scheme 14). 
However, it was established that compounds 20, 
synthesized by reaction of arylpyruvic acids and 
aldehydes [57], did not react with aminoazoles 
4, 6, 14 and, therefore, could not be intermedi-
ates in that multicomponent process. 
The authors [52] proposed the probable 
sequence that might include formation of aldols 
21 at the first stage of the high-temperature 
three-component reaction, subsequent nucleo-
philic substitution of the hydroxyl group with 
aminoazole (intermediate 22) and, ultimately, an 
intramolecular condensation (pathway “c”, 
Scheme 14). The other mechanisms cannot be 
also excluded, e.g., via arylidenephenylpyruvic 
acids 23 formed by water elimination from al-
dols 21. 
 
 
Scheme 14 
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However, Sakhno et al. [52] didn’t suc-
ceed in the attempts to synthesize the com-
pounds 23 by the direct reaction of arylpyruvic 
acids 15 and aldehydes 2 under different condi-
tion which was in good agreement with the lit-
erature data for the synthesis of similar unsatu-
rated acids [58]. 
Based on the results obtained revealing 
several rules in the proceeding condensations of 
aminoazoles and arylidenepyruvic acids (or 
their synthetic precursors) the influence of the 
modifying aminoazole on the reaction behavior 
was studied as well. Among the polyfunctional 
aminoazoles, applied in the heterocyclizations 
with carbonyl compounds, 3,5-diamino-1,2,4-
triazole is of an interest due to the presence of 
several alternative reaction centers which usual-
ly results in formation of pyrimidine structures 
with additional possibility of further modifica-
tion of the cyclization products. Moreover, in-
troduction of an aryl substituent at position 1 of 
the diaminotriazole gives rise to specific proper-
ties that have been studied in details by Cher-
nyshev et al. [59-63], Papini et al. [64-66] and 
other authors [67]. 
 
 
Scheme 15. 
However, 1-(4-clorophenyl)-3,5-
diamino-1,2,4-triazole (24) in the reaction with 
phenylpyruvic acid (15) and aromatic aldehydes 
2 showed the similar to aminotetrazole 4 behav-
ior: after the heating or MW irradiating the 
starting materials (Scheme 15) in acetic acid 
corresponding pyrrolones 25 were synthesized 
while all the attempts to isolate tetrahydropy-
rimidines like 16 (Scheme 12) were unsuccess-
ful [52]. 
The analogous multicomponent conden-
sation involving unsubstituted pyruvic acid (1) 
proceeded in an unusual direction. It was estab-
lished [68] that three-component treatment of 
diaminotriazole 24, aromatic aldehydes 2 and 
pyruvic acid (1) in boiling DMF gave unex-
pected 3-[5-amino-1-(4-chlorophenyl)-1H-
1,2,4-triazol-3-ylamino]-5-arylfuran-2-ones 26 
(Method A, Scheme 16). The authors [68] em-
phasize that neither triazolopyrimidines like 16 
(Scheme 12) nor pyrrolone derivatives of type 
25 (Scheme 15) were isolated or even chroma-
tographically detected in the mother liquor. 
The direction of the sequential reaction 
(Scheme 16, method B) via preliminary synthe-
sis of arylidenepyruvic acids 3 was identical to 
the multicomponent procedure. 
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Scheme 16. 
It was found that refluxing diaminotria-
zole 24 and unsaturated acids 3 in DMF led to 
the formation of the same triazolofuranones 26, 
however the yields were smaller [68]. 
An alternative direction leading to tria-
zolopyrimidines 27 was disfavored owing to the 
fact of a loss of aromaticity by the aminoazole 
moiety during the reaction (Scheme 16). 
The most probable way for the formation 
of triazolylfuranones 26 was suggested in publi-
cation [68] and included the attack of one of the 
NH2 groups of diaminotriazole 24 on the β-
carbonyl group of pyruvic acid (1) with for-
mation of azometines 28 followed by the cy-
clization with an aldehyde component 2 into the 
corresponding furanones 26 (Scheme 17). For-
mation of imines like 28 in analogues heterocy-
clizations involving aromatic or heterocyclic 
amines and pyruvic acids was previously de-
scribed and discussed in several works [69-73]. 
According to the authors [68], other possible 
pathways, e.g., via preliminary in situ formation 
of arylidenepyruvic acids 3 or even whole 
furanone moiety were doubtful because of the 
previous negative results obtained for analogues 
multicomponent reactions (Scheme 14) [45, 
52]. 
On the other hand, the fact of isolation of 
triazolylpyrrolones 25 in the reaction involving 
phenylpyruvic acid (15) [52] (Scheme 15) can 
be explained by the specific influence of the 
phenyl substituent preventing the formation of 
the intermediate like 29. 
Similarly, the mechanism of the sequen-
tial reaction (Scheme 17) leading to the 
furanones 26 can take place via formation of 
imines 29 and their further cyclization into the 
final compounds 26. 
Reactions of 5-aminopyrazoles with py-
ruvic acids can also proceed in several direc-
tions and lead to fused pyridine or pyrimidine 
carboxylic acids; therefore, they are interesting 
from the point of view of chemo- and regiose-
lectivity. In addition, high interest in the study 
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of pyridine and pyrimidine heterocycles con-
taining fused pyrazole rings is mainly caused by 
the known biological activity of these systems 
reported in the literature [74-77]. 
Scheme 17. 
The article [78] described the treatment 
of arylidenepyruvic acids or pyruvic acids with 
aromatic aldehydes and substituted 5-
aminopyrazoles (Scheme 18). Under thermal or 
microwave heating, these cyclocondensations 
led to fused pyridine or pyrimidine carboxylic 
acids. It was shown that refluxing on an oil bath 
of equimolar mixtures of 5-amino-3-
methylpyrazole (30) with unsaturated acids 3 in 
DMF or acetic acid allowed to obtain 4-aryl-3-
methylpyrazolo[3,4-b]pyridine-6-carboxylic ac-
ids 33 (Scheme 18). 
It should be noted that heterocyclic 
products in these reactions were not isolable as 
dihydroderivatives, which indicate the high pro-
pensity of the expected 4-aryl-3-methyl-4,7-
dihydropyrazolo[3,4-b]pyridine intermediates to 
oxidation. 
Treatment of 5-amino-3-methyl-1-
phenylpyrazole (31) with arylidenepyruvic acids 
3 in boiling DMF led to 4-aryl-3-methyl-1-
phenylpyrazolo[3,4-b]pyridine-6-carboxylic ac-
ids 34. However, the authors showed that re-
fluxing the starting materials in boiling acetic 
acid allowed obtaining their dihydroanalogs 35, 
which were accompanied by only small 
amounts of heterocycles 34. Exposure of dihy-
dropyridines 35 on air resulted in their oxidation 
to products 34. 
Refluxing arylidenepyruvic acids 3 with 
5-amino-3-arylpyrazoles 32 allowed to isolate 
the mixtures of several regioisomers and prod-
ucts of their heteroaromatization (36, 37 and 38) 
as the reaction was not regioselective in most 
cases.  
It should also be noted that condensation 
of 5-aminopyrazoles 30-32 with the unsaturated 
acids 3 have never yielded isomers with oppo-
site location of the aryl and carboxyl groups at 
the pyridine or pyrimidine rings. 
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Scheme 18. 
To solve the dilemma of obtaining the 
mixture of two regioisomers when 3-aryl-5-
aminopyrazoles 32 reacted with arylidenepyru-
vic acids 3 in boiling acetic acid the authors of 
the article [78] applied ultrasonication to this 
reaction (Scheme 19).  
 
Scheme 19. 
It was determined that cyclocondensa-
tion of the starting materials in acetic acid under 
ultrasonic irradiation at room temperature 
caused the formation of exclusively 2,7-diaryl-
4,7-dihydropyrazolo[1,5-a]pyrimidi-ne-5-
carboxylic acids 36. 
In the case of multicomponent reactions 
of pyrazoles 30-32 with pyruvic acid (1) and 
aromatic aldehydes 2 corresponding 6-aryl-3-
methylpyrazolo[3,4-b]pyridine-4-carboxylic ac-
ids 39, 1,6-diaryl-3-methylpyrazolo[3,4-
b]pyridine-4-carboxylic acids 40 or 3,6-
diarylpyrazolo[3,4-b]pyridine-4-carboxylic ac-
ids 41 were formed (Scheme 20) [78]. 
It was a very surprising discovery that 
reactions of 3-substituted 5-aminopyrazoles 30-
32 with arylidenepyruvic acids 3 and the three-
component cyclocondansation of the same pyra-
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zoles with pyruvic acids 1 and aldehydes 2 led 
to the formation of different reaction products, 
which differ in the location of the carboxylic 
and R1 substituents. It is also very important to 
mention that heteroaromatized compounds were 
formed as the result of the three-component re-
actions even under inert conditions. 
 
Scheme 20. 
However, the treatment of 5-
aminopyrazoles with arylidenepyruvic acids not 
necessary leads to the formation of pyrazo-
loazines. 
 
Scheme 21. 
The authors of the article [80] showed 
that refluxing pyrazoles 42 with unsaturated ac-
ids 3 in acetic acid allowed to obtain the mixture 
of pyrazolopyrimidine-5-carboxylic acids 43 
and pyrazolylaminofuranones 44 (Scheme 21) 
while heating the starting materials 3 and 42 in 
boiling methanol resulted in the formation of 
solely compounds 44 in high yields. 
It is important to point out that the addi-
tion of catalytic amounts of HCl had a strong 
effect on this reaction. Thus, in contrast to the 
above observation where 44 was selectively ob-
tained, addition of hydrochloric acid changed 
the direction towards compounds 43. However, 
using HCl in methanol medium has a serious 
drawback: it causes the esterification of acids 
43. To overcome this obstacle the authors [80] 
searched for the different reaction conditions 
and it was established that microwave irradia-
tion (2 min at 170oC) in acetic acid of the start-
ing materials yielded only the acids 43. 
The multicomponent reactions of pyra-
zoles 42 with pyruvic acid (1), and aldehydes 2 
led to pyrimidines 43 (Scheme 22), which were 
identical to the compounds isolated as the prod-
ucts of the two-component cyclocondensations 
(Scheme 21). 
 
Scheme 22. 
The interactions involving 3-amino-5-
methylisoxazole (45) with arylidenepyruvic ac-
ids 3 or their synthetic precursors, pyruvic acid 
(1) and aromatic aldehydes 2, resulted in the 
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formation of furanones 46 similar to compounds 
44. At the same time heating (80oC) 5-amino-3-
methylisoxazole (47), arylidenepyruvic acids 3 
in AcOH allowed to obtain only isoxa-
zolopyridinecarboxylic acids 48 (Scheme 23) 
[81]. 
 
Scheme 23. 
The influence of temperature regime on 
three-component reaction of pyrazole 42, phe-
nylpyruvic acid (15), and aromatic aldehydes 2 
was explored in publication [80]. Under ultra-
sonication of starting materials in acetic acid at 
room temperature tetrahydropyrazolopyrimi-
dine-7-carboxylic acids 49 were only formed 
(Scheme 24). 
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Scheme 24. 
On the other hand, refluxing pyrazole 
42, phenylpyruvic acid (15), and aromatic alde-
hydes 2 in acetic acid or their heating in the mi-
crowave reactor led to the formation of pyr-
rolones 50. The authors of articles [80, 81] con-
cluded that compounds 49 were the kinetically 
controlled products, while compounds 50 were 
thermodynamically controlled ones. 
Pyrrolones 51, similar to 50, were also 
obtained under refluxing 3-amino-5-
methylisoxazole (45) with aromatic aldehydes 
and arylpyruvic acid in HOAc, while the same 
three-component reaction involving isomeric 5-
amino-3-methylixazole (47) proceeded with the 
formation of the carboxylic acids 52 (Scheme 
25) [81]. 
 
Scheme 25. 
Some interesting results were found 
when 3-aryl-4-alkyl-5-aminopyrazoles 53 react-
ed with several esters of arylidenepyruvic acids 
54 – the treatment yielded esters of 6-hydroxy-
2,7-diarylpyrazolo[1,5-a]pyrimidine-5-
carboxylic acids 55 (Scheme 26) [81]. In con-
trast, carrying out the same reaction under ultra-
sonication at room temperature caused the for-
mation of the esters of 6-hydroxy-2,7-
diaryldihydropyrazolo[1,5-a]pyrimidine-5-
carboxylic acids 56 in mixtures with some 
amounts of compounds 55. It should be men-
tioned that further refluxing of compounds 56 in 
acetic acid allowed to obtain heterocycles 55; all 
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the efforts to carry out the dehydration of esters 
56 were in vain. 
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Scheme 26. 
The multicomponent reactions of pyra-
zoles 53 with ethyl pyruvate (56) and aromatic 
aldehydes 2 in boiling acetic acid also led to py-
rimidines 55 (Scheme 27) [81]. On the other 
hand, the same interaction under ultrasonication 
allowed obtaining 7-hydroxytetrahydro-
pirazolopyrimidines 57. 
 
Scheme 27. 
There were a lot of examples when the 
introduction of ortho-OH-group into aromatic 
ring of the aldehyde allowed the formation of 
several different chemotypes of final structures, 
i.e. oxygen-bridged [82-88], spiroheterocyclic 
compounds [89], lactones [85] and the other 
structures [82]. In continuation of the recent re-
search [44, 45, 52, 58, 78-80] dedicated to the 
tuning the selectivity of the reactions involving 
aminoazoles, aromatic aldehydes and pyruvic 
acids, the similar MCRs with the participation 
of ortho-hydroxybenzaldehydes were chosen as 
a challenging object for the study. It was found 
that variation of the temperature regime together 
with applying non-classical activation methods 
(ultrasonic and microwave irradiation) allowed 
to switch such reaction as well. 
Thus, the condensation of pyruvic acid 
(1) with ortho-hydroxybenzaldehydes 10 and 5-
amino-3-arylpyrazoles 32 under conventional 
refluxing in acetic acid led to the pyrazolo[3,4-
b]pyridine-4-carboxylic acids 58 (Scheme 28) 
similar to those obtained in the reactions involv-
ing other aldehydes (Scheme 20) [90]. The sub-
stances 58 might also be obtained under micro-
wave irradiation (AcOH, 150 °C, 20 min) that 
allowed a 4-fold reduction in the time of the 
process due to the higher reaction temperature 
[90]. 
However, the treatment of the same 
starting materials 1, 10 and 32 in acetic acid at 
room temperature with application of ultrasonic 
irradiation gave benzoxazocine-4-carboxylic 
acids 59 (Scheme 28). These oxygen-bridged 
heterocycles were stable upon boiling in a series 
of solvents (acetic acid, methanol, ethanol and 
butanol). However, their stirring in ethanol with 
addition of sodium hydroxide led to cleavage of 
the bridged fragment, oxidation and the for-
mation of compounds 58 in 90% yields. MW 
irradiating compounds 59 in HOAc (150 °C, 15 
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min) or heating them in DMSO for 48 hours al-
so caused the formation of heteroaromatic car-
boxylic acids 58 (Scheme 28) [90]. 
The authors [90] considered azomethines 
as the intermediates of both heterocyclizations 
mentioned above. Indeed, treatment of the cor-
responding preliminary obtained imines with 
pyruvic acid led to the formation of compounds 
58 and 59, respectively. 
 
Scheme 28. 
The possibility of the transformation 
of the azomethines into pyrazolopyridines like 
58 by refluxing with pyruvic acid had been 
described in the earlier works [78]. 
As it was mentioned above, 5-
aminopyrazoles containing a substituent in the 
fourth position sometimes possessed specific 
properties and exhibited unusual behavior in 
multicomponent reactions [80, 91, 92]. 
However, it was found that heterocy-
clization of 5-amino-4-ethyl-3-(4-
fluorophenyl)pyrazole (53) and salicylalde-
hyde (10) both with pyruvic acid (1) and with 
arylpyruvic acids 15 in acetic acid under ul-
trasonication at room temperature led to the 
tetrahydroderivatives 60 similar to the reac-
tion presented on Scheme 27 and no for-
mation of bridged structures was observed 
(Scheme 29) [90]. 
Heterocyclization of pyrazoles 32 and 
salicylaldehyde (10) with arylpyruvic acids 15 
under ultrasonic irradiation, in contrast to the 
multicomponent reactions involving pyruvic 
acid, proceeded with the formation of a py-
rimidine ring instead of a pyridine one (car-
boxylic acids 61, Scheme 29). 
 
Scheme 29. 
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Compounds 60 and 61 were also ob-
tained in the reaction of the corresponding 
azomethines with arylpyruvic acids [90]. 
Antimicrobial activity of the heterocy-
cles obtained was studied as well. For several 
of the compounds tested a sufficient increase 
in biomass of cultures compared with control 
was found [90]. 
 
Conclusions 
Thus, the known literature data 
demonstrate high potential of linear and mul-
ticomponent heterocyclizations involving 
aminoazoles, aldehydes and pyruvic acids or 
its derivatives for organic synthesis and, in 
particular, for Diversity Oriented Synthesis. 
Switchable character of such reactions and 
possibility to tune their selectivity by varia-
tion of the reaction parameters opens the 
pathway to obtain diverse heterocyclic scaf-
folds from a limited set of starting materials. 
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